[2] Proof of COVID-19 antiviral effect of EGFR inhibitor(vandetanib) (animal biological experiments - laboratory mice infected with COVID-19 virus) (IMAGE)

National Research Council of Science & Technology

[2] Proof of COVID-19 antiviral effect of EGFR inhibitor(vandetanib) (animal biological experiments - laboratory mice infected with COVID-19 virus)

Caption

▲Lung tissue qRT-PCR test results 3 days after administration → Viral RNA reduced approximately 10-fold.

▲The results of a staining test on the lung tissue inflammation area six days after administration, → Significantly alleviates lung inflammation.

Credit

Korea Research Institute of Chemical Technology(KRICT)

Usage Restrictions

The sources of photos and research results from KRICT must be specified.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.